4.8 Article

How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease?

Journal

GASTROENTEROLOGY
Volume 162, Issue 5, Pages 1439-1451

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2021.08.060

Keywords

Crohn's Disease; Ulcerative Colitis; Depression; Anxiety; Treat-To-Target

Ask authors/readers for more resources

Early diagnosis and optimal control of inflammation are best practices for managing inflammatory bowel disease. Patients often experience challenging symptoms, such as abdominal pain, fatigue, depression, and anxiety, that are not properly addressed. This review highlights the burden of these symptoms, suggests assessment methods, and emphasizes the importance of acknowledging and validating patient's symptoms.
Early diagnosis and the optimal control of inflammation, with a continuous cycle of assessment, treatment, monitoring, and adjustment of therapy, is best practice for the management of inflammatory bowel disease. However, patients express frustration with ongoing challenging symptoms, often discordant with inflammation, including abdominal pain, fatigue, depression, anxiety, and emotional wellness; these are often not optimally addressed by inflammatory bowel disease clinicians due to lack of time or resources. This review will highlight the burden of these symptoms and issues, suggest ways of assessing these in clinical practice, highlight the importance of acknowledging and validating the symptoms and issues with patients, reassuring them that they are being heard, and discuss different possible models of service delivery for psychosocial support, from fully integrated gastropsychology models to referral pathways that optimize community support. We suggest the importance of the treat-to-target concept, where the target is not only control of inflammation but also emotional wellness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available